BHVN · Biohaven Ltd
United States · RS rating 92 · As of 2026-11-03
| Price | 15.61 USD |
|---|---|
| 1-day change | +3.0% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 94 / 86 / 44 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 50 / 54 / 77 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +26.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +7.9% |
| Market cap (USD) | $1.6B |